eyes-2843185_1920.jpg

20/20 OPTIMEYES 

μ-celle is a mucoadhesive anterior segment drug delivery platform. By encapsulating drugs and binding to the ocular surface, we can greatly reduce dosing frequency, and improve clinical efficacy through controlled release. 

 

In collaboration with: 

Screen Shot 2018-01-04 at 3.34.26 PM.png